ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 475,52
0,93%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Oric Pharmaceuticals Inc (ORIC)

  7. Oric Pharmaceuticals Inc (ORIC) Actualités

ORIC Oric Pharmaceuticals Inc

9,71
0,19 (2,00%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Oric Pharmaceuticals Inc ORIC NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,19 2,00% 9,71 00:00:02
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
9,77 9,48 10,05 9,71 9,52
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/5/202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
15/4/202422:15GLOBEORIC Pharmaceuticals Announces First Patients Dosed Across..
08/4/202414:00GLOBEORIC Pharmaceuticals Presents Preclinical Data on Two..
05/4/202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
04/4/202422:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
11/3/202422:28EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/3/202421:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202421:10EDGAR2Form 8-K - Current report
11/3/202421:05GLOBEORIC Pharmaceuticals Reports Fourth Quarter and Full Year..
06/3/202422:30GLOBEORIC Pharmaceuticals to Present at the Leerink..
05/3/202422:30GLOBEORIC Pharmaceuticals Announces Multiple Presentations at the..
01/3/202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
14/2/202422:30GLOBEORIC Pharmaceuticals to Participate in the Citi 2024 Virtual..
05/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02/2/202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
31/1/202422:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
26/1/202422:58EDGAR2Form S-3 - Registration statement under Securities Act of..
25/1/202419:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
22/1/202415:01EDGAR2Form 8-K - Current report
22/1/202414:30GLOBEORIC Pharmaceuticals Announces $125 Million Private..
09/1/202415:00EDGAR2Form 8-K - Current report
08/1/202414:30GLOBEORIC Pharmaceuticals Provides Initial Phase 1b Data for..
02/1/202422:30GLOBEORIC Pharmaceuticals to Present at the 42nd Annual J.P...
15/12/202322:32EDGAR2Form S-3 - Registration statement under Securities Act of..
11/12/202322:05EDGAR2Form 8-K - Current report
11/12/202318:00GLOBEInitial Phase 1 Dose Escalation Data for ORIC-533 in..
01/12/202322:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
09/11/202322:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
06/11/202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:10EDGAR2Form 8-K - Current report
06/11/202322:10GLOBEORIC Pharmaceuticals Reports Third Quarter 2023 Financial..
03/11/202321:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
02/11/202314:00GLOBEORIC Pharmaceuticals to Present Initial Phase 1b Clinical..
23/10/202322:07EDGAR2Form 8-K - Current report
21/10/202313:30GLOBEInitial Phase 1 Dose Escalation Data of ORIC-114 in Patients..
17/10/202322:30GLOBEORIC Pharmaceuticals to Present Initial Phase 1b Clinical..
06/10/202322:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
20/9/202322:30GLOBEORIC Pharmaceuticals to Participate in the 2023 Cantor..
01/9/202322:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
30/8/202322:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
10/8/202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:11EDGAR2Form 8-K - Current report
10/8/202322:05GLOBEORIC Pharmaceuticals Reports Second Quarter 2023 Financial..
04/8/202322:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
07/7/202322:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/6/202314:30GLOBEORIC Pharmaceuticals Announces $85 Million Private Placement..
02/6/202322:15GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
31/5/202322:10GLOBEORIC Pharmaceuticals to Participate in the Jefferies..
08/5/202322:05GLOBEORIC Pharmaceuticals Reports First Quarter 2023 Financial..
05/5/202322:15GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..

Dernières Valeurs Consultées

NASDAQ
ORIC
Oric Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés